The Hartland Oration
As VIIN Co-Convenor, Professor Elizabeth Hartland had key roles in co-convening the Lorne Infection and Immunity Conferences (2011-2017), the VIIN Industry Alliance (2012-2014) and the VIIN Young Investigator Symposia (2009 – 2016). Together with Co-Convenor Professor Paul Hertzog, Liz oversaw the roll-out of VIIN’s new website, its increasing presence on social media, implementation of the VIIN’s annual careers evenings (2013-2017) and numerous other initiatives.
In honour of Liz’s contribution to VIIN, the network is delighted to announce that the awardee of the best VIIN Young Investigator Symposium ECR talk will deliver the Hartland Oration at the Lorne Infection and Immunity Conference in 2018 and onward. This outstanding young researcher will receive free registration to the Lorne Conference and $500 toward their accommodation, meals and transport.
Professor Hartland says:
“I am very proud of the momentum and support that we have created for infection and immunity research over the last several years. Our inclusive policy means that every researcher, from junior to senior levels, with an interest in infection and immunity can enjoy interactions with their peers at relaxed and social events, thereby building their own networks. To see the Lorne Infection and Immunity meeting become a national meeting is also very satisfying. We couldn’t do this without the support of our member organizations and I remain very grateful for their ongoing contributions.”
Hartland Orators:
2026: Dr Thomas McLean, The Walter and Eliza Hall Institute for Medical Research, “Structural basis of DNA sliding clamp-mediated long-range gene silencing on a multi-drug resistance plasmid”
2025: Dr Lynn Nazareth, Australian Centre for Disease Preparedness, CSIRO, “Development of ex vivo models of nasal epithelia to elucidate the mechanism of Bordetella bronchiseptica-mediated blockade of influenza virus replication in the nasal cavity”
2024: Dr Paula M Cevaal, Peter Doherty Institute for Infection and Immunity & University of Melbourne, “Potent, HIV-specific latency reversal through CRISPR activation delivered by lipid nanoparticles exhibiting a high efficiency of transfecting resting CD4+ T cells with minimal toxicity”
2023: Dr Harshini Weerasinghe, Monash University, “Eat to compete: Understanding immunometabolic interactions that drive Candida auris infection”
2022: Dr Ebony A Monson, La Trobe University, “Analysis of the Dynamics and Composition of Lipid Droplets During Viral Infection”
2021: Dr Niall D Geoghegan, The Walter and Eliza Hall Institute of Medical Research, “Quantitative 4D microscopy of P. falciparum invasion of erythrocytes”
2020: Dr Stephen W Scally, The Walter and Eliza Hall Institute of Medical Research, “Structural studies of human antibody responses against leading malaria vaccine antigen PfCSP.”
2018: Dr Angela Pizzolla, University of Melbourne, “Nasal tissue resident memory CD8+ T cells prevent pulmonary influenza A virus infection.”
The Hartland Oration is one of two prestigious orations at the Lorne Infection and Immunity Conference, with the Hertzog Oration recognising the other founding co-convenor of VIIN, Prof Paul Hertzog: https://www.viin.org.au/news/the-hertzog-oration.
For up to date information about the Lorne Infection and Immunity conference, please see here: http://www.lorneinfectionimmunity.org/
Photo credit: Linda Peake, Hudson Institute of Medical Research.